Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study
Daniel Aletaha, Clifton O. Bingham, Yoshiya Tanaka, Prasheen Agarwal, Regina Kurrasch, Paul P. Tak, Sharon Popik
Dive into the research topics of 'Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study'. Together they form a unique fingerprint.